GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Seelos Therapeutics Inc (STU:NXE0) » Definitions » Net Interest Income (for Banks)

Seelos Therapeutics (STU:NXE0) Net Interest Income (for Banks)


View and export this data going back to 2010. Start your Free Trial

What is Seelos Therapeutics Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Seelos Therapeutics (STU:NXE0) Business Description

Traded in Other Exchanges
Address
300 Park Avenue, 2nd Floor, New York, NY, USA, 10022
Seelos Therapeutics Inc is a clinical-stage biotechnology company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders.